Loading clinical trials...
Loading clinical trials...
Effects of a Tactical Programme for Critical Thinking (TPCT) on Tactical Efficiency in Elite Women's Underwater Rugby: a Randomised Controlled Trial
This randomized controlled trial evaluates whether adding a short, structured team-reflection protocol (Tactical Programme for Critical Thinking, TPCT) to regular elite women's underwater rugby training improves tactical efficiency. Both groups complete the same training content and time; the TPCT group uses brief guided discussion during recovery intervals, while the control group uses the same time for passive recovery. Tactical efficiency is assessed using video-recorded 3v3 scrimmages coded with the RUSTAC checklist at baseline and after 6 weeks.
A parallel, two-arm randomized controlled trial will be conducted in an elite women's underwater rugby squad. Players will be allocated 1:1 to TPCT or an active control condition using a computer-generated random sequence. The intervention consists of 18 sessions over 6 weeks (3/week), 2 hours per session, delivered in an outdoor 4 m pool and a marked 10 m × 8 m underwater area. Sessions include a short coach introduction (\~15 min), constrained small-sided games designed to elicit target tactical principles, and ≥60 min free-play (≥50% of session) to preserve representativeness and transfer. The TPCT condition embeds \~3 min structured reflection between small-sided bouts using a fixed 5-question protocol aligned to critical thinking operations; the control condition uses equivalent between-bout time for passive recovery/hydration.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
Yes
Tecnológico de Antioquia
Medellín, Colombia
Start Date
May 1, 2026
Primary Completion Date
July 1, 2026
Completion Date
September 1, 2026
Last Updated
March 9, 2026
26
ESTIMATED participants
Matched Tactical Training Programme (MTT)
BEHAVIORAL
Tactical Programme for Critical Thinking (TPCT) - Structured Reflective Questioning
BEHAVIORAL
Lead Sponsor
Federal University of Vicosa
NCT07253181
NCT07464899
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions